Live Quote · NASDAQKNTEHealthcare · Biotechnology

Kinnate Biopharma Inc.

$2.65▼ 0.38%($-0.01)

MKT CAP $124.99MLAST EARNINGS May 9, 2024

50%

Bullish

50%

Bullish

TickerSpark Score

68/100

▌ Solid

80

Valuation

35

Profitability

40

Growth

84

Health

100

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KNTE research report →

Analyst Price Target

$30.00+1032.1% vs. today

Range $30 – $30

Analyst RatingHold

2 Buy4 Hold0 Sell

Price Chart

-61.26% · this period

52-Week Range26% of range

Low

$1.04

Current

$2.65

High

$7.18

Float & Shares

Free Float: 48.1%
Shares Outstanding: 47.17M
Float Shares: 22.68M

Institutional Ownership

82.3%

of shares held by institutions

63 13F filers

Insider ActivityLast quarter

0 Buys50 Sells

Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.

13F Holders · KNTE

Top institutional holders

Largest 13F positions, with quarter-over-quarter change.

Holder	Shares	Δ Quarter
Foresite Capital Opportunity Management V, LLC	291.67K	0
Parametric Portfolio Associates LLC	36.42K	▲ 22.74K
Amalgamated Financial Corp.	3.17K	▲ 3.17K
Wipfli Financial Advisors LLC,	109	▲ 109

ETF Exposure · KNTE

Held by 2 ETFs

Biggest fund positions in KNTE by dollar value.

PQSG

0.2% wt$20.66K

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Apr 3, 24	Tananbaum James B.	director, 10 percent owner:	sell	40,501	$810.02K
Apr 3, 24	Tananbaum James B.	director, 10 percent owner:	sell	20,250	$169.70K
Apr 3, 24	Tananbaum James B.	director, 10 percent owner:	sell	520,711	$1.35M
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	750,000	$5.08M
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	275,000	$9.73M
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	2,186	$5.66K
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	1,281,642	$3.29M
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	400,000	$4.01M
Apr 3, 24	Farzan Nima	director, officer: CHIEF EXECUTIVE OFFICER	sell	437,413	$2.46M
Apr 3, 24	MITCHELL DEAN J	director	sell	20,250	$169.70K

A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.

Kinnate Biopharma Inc.

Price Chart

About the company

Get TickerSpark's AI analysis on KNTE

Similar companies

Top institutional holders

Held by 2 ETFs

Recent insider transactions

Our KNTE coverage

No research on KNTE yet